XML 74 R4.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
 3 Months Ended 12 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Mar. 31, 2021
Mar. 31, 2020
Revenue, net $ 7,735 $ 1,576 $ 23,795 $ 67,689
Operating expenses:        
Cost of revenues 742 180 2,057 1,131
Research and development 78,626 58,734 832,758 263,217
General and administrative 82,754 57,115 259,878 335,766
Total operating expenses 162,122 116,029 1,094,693 600,114
Loss from operations (154,387) (114,453) (1,070,898) (532,425)
Other income (expense):        
Change in fair value of investments 8,619 (41,148) (95,533) 136,005
Change in fair value of debt and liability instruments 4,585 17,125 29,845 (13,722)
Gain on termination of Sumitomo Options (66,472) 0    
Gain on deconsolidation of subsidiary 0 (86,516) (115,364) (107,344)
Gain on deconsolidation of subsidiary and consolidation of unconsolidated entity     (115,364) (107,344)
Other (income) expense, net (134) 2,842 8,701 13,622
Loss from continuing operations before income taxes     (898,547) (560,986)
Loss before income taxes (100,985) (6,756)    
Income tax expense 93 1,221 1,686 7,124
Loss from continuing operations, net of tax     (900,233) (568,110)
Income from discontinued operations, net of tax     0 1,578,426
Net loss (101,078) (7,977) (900,233) 1,010,316
Net loss attributable to noncontrolling interests (18,895) (4,734) (90,999) (190,193)
Net loss attributable to Roivant Sciences Ltd. (82,183) (3,243) (809,234) 1,200,509
Amounts attributable to Roivant Sciences Ltd.:        
Loss from continuing operations, net of tax     (809,234) (519,394)
Income from discontinued operations, net of tax     0 1,719,903
Net (loss) income attributable to Roivant Sciences Ltd. $ (82,183) $ (3,243) $ (809,234) $ 1,200,509
Basic and diluted net (loss) income per common share:        
Basic and diluted loss from continuing operations     $ (3.76) $ (2.72)
Basic and diluted income from discontinued operations     0 7.85
Net loss per common share—basic and diluted $ (0.37) $ (0.02) $ (3.76) $ 5.13
Basic and diluted weighted average shares outstanding:        
Basic     215,312,273 219,036,630
Diluted     215,312,273 219,036,630
Weighted average shares outstanding—basic and diluted 222,081,975 214,879,058